Last reviewed · How we verify

Progesterone Vaginal Gel 8%

Eastern Virginia Medical School · Phase 2 active Small molecule

Progesterone Vaginal Gel 8% is a Small molecule drug developed by Eastern Virginia Medical School. It is currently in Phase 2 development. Also known as: Crinone 8% vaginal gel.

At a glance

Generic nameProgesterone Vaginal Gel 8%
Also known asCrinone 8% vaginal gel
SponsorEastern Virginia Medical School
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Progesterone Vaginal Gel 8%

What is Progesterone Vaginal Gel 8%?

Progesterone Vaginal Gel 8% is a Small molecule drug developed by Eastern Virginia Medical School.

Who makes Progesterone Vaginal Gel 8%?

Progesterone Vaginal Gel 8% is developed by Eastern Virginia Medical School (see full Eastern Virginia Medical School pipeline at /company/eastern-virginia-medical-school).

Is Progesterone Vaginal Gel 8% also known as anything else?

Progesterone Vaginal Gel 8% is also known as Crinone 8% vaginal gel.

What development phase is Progesterone Vaginal Gel 8% in?

Progesterone Vaginal Gel 8% is in Phase 2.

Related